Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Blake

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
British Journal of Urology|April 1, 1985
Thallium-technetium subtraction scintigraphy as an aid to parathyroid surgeryR C Percival, G M Blake, G H Urwin, et al.
Nuclear Medicine Communications|September 1, 1985
Adrenal scintigraphy with 75Se selenonorcholestenol: a reviewC J Sudell, G M Blake, A A Gossage, et al.
Bone|December 9, 2008
Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXAG M Blake, J F Griffith, D K W Yeung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 1998
Morphometric X-ray absorptiometry: reference data for vertebral dimensionsJ A Rea, P Steiger, G M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1989
89Sr therapy: strontium plasma clearance in disseminated prostatic carcinomaG M Blake, J F Wood, P J Wood, et al.
The British Journal of Radiology|March 1, 1987
Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcomaG M Blake, M A Zivanovic, A J McEwan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2000
Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformityJ A Rea, J Li, G M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
Nuclear Medicine Communications|May 1, 1990
Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinomaJ C Watkinson, S Allen, C R Lazarus, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Urology|April 1, 1985
Thallium-technetium subtraction scintigraphy as an aid to parathyroid surgeryR C Percival, G M Blake, G H Urwin, et al.
Nuclear Medicine Communications|September 1, 1985
Adrenal scintigraphy with 75Se selenonorcholestenol: a reviewC J Sudell, G M Blake, A A Gossage, et al.
Bone|December 9, 2008
Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXAG M Blake, J F Griffith, D K W Yeung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 1998
Morphometric X-ray absorptiometry: reference data for vertebral dimensionsJ A Rea, P Steiger, G M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1989
89Sr therapy: strontium plasma clearance in disseminated prostatic carcinomaG M Blake, J F Wood, P J Wood, et al.
The British Journal of Radiology|March 1, 1987
Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcomaG M Blake, M A Zivanovic, A J McEwan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2000
Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformityJ A Rea, J Li, G M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
Nuclear Medicine Communications|May 1, 1990
Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinomaJ C Watkinson, S Allen, C R Lazarus, et al.
Pageof 13